Medpace Holdings's EBIT per Share for the
three
months ended in Mar. 2024 was $3.25.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $11.13.
During the past 12 months, the average EBIT per Share Growth Rate of Medpace Holdings was 20.60% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 33.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 31.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Medpace Holdings's EBIT per Share or its related term are showing as below:
MEDP'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -2 Med: 33.7 Max: 53.7
Current: 33.7
During the past 11 years, the highest 3-Year average EBIT per Share Growth Rate of Medpace Holdings was 53.70% per year. The lowest was -2.00% per year. And the median was 33.70% per year.
MEDP's 3-Year EBIT Growth Rate is ranked better than 82.58% of 178
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.6
vs MEDP: 33.70
The historical data trend for Medpace Holdings's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.13
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medpace Holdings (NAS:MEDP) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Medpace Holdings EBIT per Share Related Terms
Thank you for viewing the detailed overview of Medpace Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Medpace Holdings (Medpace Holdings) Business Description
Medpace is a late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device firms. Medpace also offers ancillary services such as bio-analytical laboratory services and imaging capabilities. The company was founded over 30 years ago, and it has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are principally based in the U.S., but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in February 2014, and it exited Medpace in August 2018.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MEDP has been successfully added to your 